Principles and practice of pharmaceutical medicine /

Saved in:
Bibliographic Details
Edition:2nd ed.
Imprint:Chichester, West Sussex ; Hoboken, NJ : John Wiley & Sons, c2007.
Description:1 online resource.
Language:English
Subject:
Format: E-Resource Book
URL for this record:http://pi.lib.uchicago.edu/1001/cat/bib/8384208
Hidden Bibliographic Details
Other authors / contributors:Edwards, Lionel D.
ISBN:9780470093146 (electronic bk.)
0470093145 (electronic bk.)
9780470851715
6610855005 (electronic bk.)
9786610855001 (electronic bk.)
0470093137 (Cloth)
Notes:Includes bibliographical references and index.
Description based on print version record.
Other form:Print version: Principles and practice of pharmaceutical medicine. 2nd ed. Chichester, West Sussex ; Hoboken, NJ : John Wiley & Sons, c2007 9780470093139 0470093137
Table of Contents:
  • Preface to the First Edition
  • Preface to the Second Edition
  • About the Editors
  • Contributors
  • Section I. Overview of Pharmaceutical Medicine
  • 1. The Practice and Practitioners of Pharmaceutical Medicine
  • 2. Pharmaceutical Medicine as a Medical Specialty
  • 3. Clinical Research Education and Training for Biopharmaceutical Staff
  • Section II. Drug Discovery and Development
  • Introduction
  • 4. Drug Discovery: Design and Serendipity
  • 5. Pharmaceutics
  • 6. Non-clinical Toxicology
  • 7. Informed Consent
  • 8. Phase I: The First Opportunity for Extrapolation from Animal Data to Human Exposure
  • 9. Phase II and Phase III Clinical Studies
  • 10. Phase IV Drug Development: Post-Marketing Studies
  • 11. Site Management
  • 12. Good Clinical Practices
  • 13. Quality Assurance, Quality Control, and Audit
  • 14. The Unique Role of Over-the-counter Medicine
  • Section III. Special Populations and Required Special Studies
  • Introduction
  • 15. Drug Research in Older Patients
  • 16. Drug Development Research in Women
  • 17. Clinical Research in Children
  • 18. Racial and Ethnic Issues in Drug Registration
  • 19. Hepatic and Renal Failure
  • 20. Drug Interactions
  • 21. Orphan Drugs
  • Section IV. Applied Aspects of Drug Development
  • Introduction
  • 22. Biotechnology Products and Development
  • 23. Pharmacoeconomics: Economic and Humanistic Outcomes
  • 24. Pharmacoepidemiology and the Pharmaceutical Physician
  • 25. Statistical Principles and Application in Biopharmaceutical Research
  • 26. Data Management
  • 27. Patient Compliance: Pharmionics, A New Discipline
  • 28. Monitoring Drug Concentrations in Clinical Practice
  • 29. Generics
  • 30. Complementary Medicines
  • Section V. Drug Regulation
  • Introduction
  • 31. United States Regulations
  • 32. Special US Regulatory Procedures: Emergency and Compassionate INDs and Accelerated Product Approvals
  • 33. The Development of Human Medicines Control in Europe From Classical Times to the Year 2000
  • 34. Medicines Regulation in the European Union
  • 35. Japanese Regulations
  • 36. Drug Registration and Pricing in the Middle East
  • Section: VI. Medical Services
  • Introduction
  • 37. Medical Affairs
  • 38. Drug Labeling
  • 39. Drug Surveillance
  • 40. Data Mining
  • 41. Risk Management in Product Approval and Marketing
  • 42. Publishing Clinical Studies
  • 43. Organizing and Planning Lo